Clinical Gastroenterology and Hepatology

Slides:

Advertisements

Similar presentations

Irritable Bowel Syndrome and Microscopic Colitis: A Systematic Review and Meta- analysis Eline J.C.A. Kamp, John S. Kane, Alexander C. Ford Clinical Gastroenterology.

Advertisements

Risk of Neoplasia After Colectomy in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis Lauranne A.A.P. Derikx, Loes H.C.

Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease and Previous Cancer Exposed to Immunosuppressive and Anti-Tumor Necrosis Factor.

The Role of Psychosocial Care in Adapting to Health Care Reform

Volume 126, Issue 1, Pages (January 2004)

Ashwin N. Ananthakrishnan, Millie D. Long, Christopher F

Use of Biologic Therapy by Pregnant Women With Inflammatory Bowel Disease Does Not Affect Infant Response to Vaccines Dawn B. Beaulieu, Ashwin N. Ananthakrishnan,

Noncardiac Chest Pain Clinical Gastroenterology and Hepatology

Vaccination and Risk for Developing Inflammatory Bowel Disease: A Meta-Analysis of Case–Control and Cohort Studies Guillaume Pineton de Chambrun, Luc.

Millie D. Long, Bruce E. Sands

Nitsan Maharshak, Scott E. Plevy

Systematic Review of Tumor Necrosis Factor Antagonists in Extraintestinal Manifestations in Inflammatory Bowel Disease Laurent Peyrin-Biroulet, Gert.

Impact of Obesity on Bowel Preparation for Colonoscopy

Combining Biologics in Inflammatory Bowel Disease and Other Immune Mediated Inflammatory Disorders Robert P. Hirten, Marietta Iacucci, Shailja Shah,

Pichamol Jirapinyo, Christopher C. Thompson

Heterogeneity in Definitions of Endpoints for Clinical Trials of Ulcerative Colitis: A Systematic Review for Development of a Core Outcome Set Christopher.

Gauree Gupta, Ebbing Lautenbach, James D. Lewis

Validation of the Ulcerative Colitis Colonoscopic Index of Severity and Its Correlation With Disease Activity Measures Sunil Samuel, David H. Bruining,

Celiac Disease and Persistent Symptoms

Volume 133, Issue 1, Pages (July 2007)

Prevalence of Irritable Bowel Syndrome–type Symptoms in Patients With Celiac Disease: A Meta-analysis Anita Sainsbury, David S. Sanders, Alexander C.

Risk of Lymphoma Associated With Combination Anti–Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease: A Meta-Analysis

Evidence for Life Before Inflammatory Bowel Disease

Computed Tomography Enterography Detects Intestinal Wall Changes and Effects of Treatment in Patients With Crohn's Disease David H. Bruining, Edward.

Gary R. Lichtenstein, Brian G. Feagan, Russell D. Cohen, Bruce A

Volume 151, Issue 1, Pages e4 (July 2016)

Translating Improved Quality of Care Into an Improved Quality of Life for Patients With Inflammatory Bowel Disease Corey A. Siegel, John I. Allen, Gil.

Effects of Concomitant Immunomodulator Therapy on Efficacy and Safety of Anti–Tumor Necrosis Factor Therapy for Crohn’s Disease: A Meta-analysis of Placebo-controlled.

Adverse Events Do Not Outweigh Benefits of Combination Therapy for Crohn's Disease in a Decision Analytic Model Corey A. Siegel, Samuel R.G. Finlayson,

Volume 147, Issue 3, Pages e3 (September 2014)

Traveling Internationally: Avoiding and Treating Travelers' Diarrhea

AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review Jean-Frederic Colombel,

Millie D. Long, Hans H. Herfarth, Clare A. Pipkin, Carol Q

Leon P. McLean, Jonathan S. Chun, Raymond K. Cross

Population Health Management for Inflammatory Bowel Disease

Clinical Gastroenterology and Hepatology

Incidence, Risk Factors, and Outcomes of Colorectal Cancer in Patients With Ulcerative Colitis With Low-Grade Dysplasia: A Systematic Review and Meta-analysis

David H. Bruining, William J. Sandborn

Histologic Changes in Liver Tissue From Patients With Chronic Hepatitis B and Minimal Increases in Levels of Alanine Aminotransferase: A Meta-analysis.

Annual Burden and Costs of Hospitalization for High-Need, High-Cost Patients With Chronic Gastrointestinal and Liver Diseases Nghia H. Nguyen, Rohan.

Volume 133, Issue 3, Pages (September 2007)

Peter Bytzer Clinical Gastroenterology and Hepatology

Volume 151, Issue 1, Pages e4 (July 2016)

Paternal Disease Activity Is Associated With Difficulty in Conception Among Men With Inflammatory Bowel Diseases Ashwin N. Ananthakrishnan, Christopher.

Mucosal Healing Is Associated With Improved Long-term Outcomes of Patients With Ulcerative Colitis: A Systematic Review and Meta-analysis Shailja C.

Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome Lilian Dindo, PhD Clinical Gastroenterology.

Risk of Cerebrovascular Accidents and Ischemic Heart Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis Siddharth.

Issue Highlights Clinical Gastroenterology and Hepatology

Issue Highlights Clinical Gastroenterology and Hepatology

Volume 155, Issue 3, Pages e10 (September 2018)

Safety of Long-term Treatment With Certolizumab Pegol in Patients With Crohn's Disease, Based on a Pooled Analysis of Data From Clinical Trials Edward.

Nicolas Williet, William J. Sandborn, Laurent Peyrin–Biroulet

Probiotics Prevent Hepatic Encephalopathy in Patients With Cirrhosis: A Randomized Controlled Trial Manish Kumar Lunia, Barjesh Chander Sharma, Praveen.

Temporal Trends in Initiation of Therapy With Tumor Necrosis Factor Antagonists for Patients With Inflammatory Bowel Disease: A Population-based Analysis

Volume 126, Issue 1, Pages (January 2004)

Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease and Previous Cancer Exposed to Immunosuppressive and Anti-Tumor Necrosis Factor.

Hepatic Cyst? Clinical Gastroenterology and Hepatology

Rocco Ricciardi, Robert D. Madoff, David A. Rothenberger, Nancy N

A 27-Year-Old Woman With Constipation: Diagnosis and Treatment

Christopher Hung, Desmond Leddin

Colocolonic Intussusception Secondary to an Intraluminal Lipoma

Endoscopic Assessment and Treating to Target Increase the Likelihood of Mucosal Healing in Patients With Crohn’s Disease Guillaume Bouguen, Barrett G.

Issue Highlights Clinical Gastroenterology and Hepatology

Risk of Pancreatitis in Patients With Celiac Disease: Is Autoimmune Pancreatitis a Biologically Plausible Mechanism? John S. Leeds, David S. Sanders

Issue Highlights Clinical Gastroenterology and Hepatology

Adverse Outcomes: Why Bad Things Happen to Good People

Medical Therapy for Refractory Pediatric Crohn’s Disease

The Role of Psychosocial Care in Adapting to Health Care Reform

Combination Therapy With Infliximab and Azathioprine Improves Infliximab Pharmacokinetic Features and Efficacy: A Post Hoc Analysis Jean-Frédéric Colombel,

Jordan E. Axelrad, Sharyle A. Fowler, Sonia Friedman, Ashwin N

Presentation transcript:

Clinical Gastroenterology and Hepatology Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases Joseph Meserve, Satimai Aniwan, Jenna L. Koliani-Pace, Preeti Shashi, Aaron Weiss, David Faleck, Adam Winters, Shreva Chablaney, Gursimran Kochhar, Brigid S. Boland, Siddharth Singh, Robert Hirten, Eugenia Shmidt, Justin G. Hartke, Prianka Chilukuri, Matthew Bohm, Sashidhar Varma Sagi, Monika Fischer, Dana Lukin, David Hudesman, Shannon Chang, Youran Gao, Keith Sultan, Arun Swaminath, Nitin Gupta, Sunanda Kane, Edward V. Loftus, Bo Shen, Bruce E. Sands, Jean-Frederic Colombel, Corey A. Siegel, William J. Sandborn, Parambir S. Dulai Clinical Gastroenterology and Hepatology DOI: 10.1016/j.cgh.2018.09.035 Copyright © 2018 AGA Institute Terms and Conditions

Figure 1 Proportions of patients on vedolizumab therapy developing serious adverse events or infections when stratified by concomitant immunosuppressive therapy. Clinical Gastroenterology and Hepatology DOI: (10.1016/j.cgh.2018.09.035) Copyright © 2018 AGA Institute Terms and Conditions

Figure 2 Proportions of patients on vedolizumab therapy developing infections when stratified by concomitant immunosuppressive (IS) therapy and key treatment history. TNF, tumor necrosis factor. Clinical Gastroenterology and Hepatology DOI: (10.1016/j.cgh.2018.09.035) Copyright © 2018 AGA Institute Terms and Conditions

Supplementary Figure 1 Flow chart of patient inclusion. Clinical Gastroenterology and Hepatology DOI: (10.1016/j.cgh.2018.09.035) Copyright © 2018 AGA Institute Terms and Conditions